Skip to main content
SpringerLink
Log in

Development of atrial fibrillation in patients with rheumatic mitral valve disease in sinus rhythm

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

This study evaluated the predictors of atrial fibrillation (AF) and adverse clinical events in patients with rheumatic mitral stenosis (RMS) in sinus rhythm. The patients who diagnosed with RMS in sinus rhythm were evaluated retrospectively between March 2003 and June 2013. The primary outcome was the development of new-onset AF with annual event rates and the secondary outcome was the incidence of clinical events including development of new-onset AF, systemic embolism and all-cause death during follow-up. Among 293 patients, AF developed in 60 (20.5 %) patients with average annual event rate of 3.5 %/year during mean follow-up period of 68.2 ± 36.6 months (median 72 months). All cause death or systemic embolism occurred in 7.2 % (21 patients; all cause death 9, embolism 12) with an average annual event rate of 2.1 %. In the multivariate analysis, large left atrium (LA) dimension and severe mitral stenosis (≤1.5 cm2) were independent predictors of AF development [HR 1.06, 95 % CI: 1.02–1.10; P = 0.001, HR 1.97, 95 % CI: 1.06–4.14; P = 0.032] after adjustment for confounding factors. Patients with enlarged LA (≥47 mm) had an average annual AF development rate of 6.0 %/year. In patients with RMS in sinus rhythm, annual AF development rate was 3.5 %/year and increased according to LA size and mitral stenosis (MS) severity. Because of very high risk embolism, RMS with enlarged LA dimension need focused follow up for early detection of AF development and clinical events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

AF:

Atrial fibrillation

CI:

Confidence interval

CT:

Computed tomographic

ECG:

Electrocardiography

EROA:

Effective regurgitation orifice area

GFC:

Global fibrinolytic capacity

GFR:

Glomerular filtration rate

HR:

Hazard ratio

LA:

Left atrium

MR:

Mitral regurgitation

MRI:

Magnetic resonance imaging

MS:

Mitral stenosis

MVA:

Mitral valve area

PISA:

Proximal isovelocity surface area

RMS:

Rheumatic mitral stenosis

TTE:

Transthoracic echocardiography

References

  1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, American College of Cardiology/American Heart Association Task Force on Practice G (2008) 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 52(13):e1–e142

    Article  PubMed  Google Scholar 

  2. Carabello BA (2005) Modern management of mitral stenosis. Circulation 112(3):432–437

    Article  PubMed  Google Scholar 

  3. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM, Thomas JD (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. doi:10.1016/j.jacc.2014.02.536

    Google Scholar 

  4. Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33(19):2451–2496

    Article  Google Scholar 

  5. Chiang CW, Lo SK, Ko YS, Cheng NJ, Lin PJ, Chang CH (1998) Predictors of systemic embolism in patients with mitral stenosis. A prospective study. Ann Intern Med 128(11):885–889

    Article  CAS  PubMed  Google Scholar 

  6. Manjunath CN, Srinivasa KH, Panneerselvam A, Prabhavathi B, Ravindranath KS, Rangan K, Dhanalakshmi C (2011) Incidence and predictors of left atrial thrombus in patients with rheumatic mitral stenosis and sinus rhythm: a transesophageal echocardiographic study. Echocardiography 28(4):457–460

    Article  PubMed  Google Scholar 

  7. Diker E, Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S, Erdogan A, Goksel S (1996) Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 77(1):96–98

    Article  CAS  PubMed  Google Scholar 

  8. Wunderlich NC, Beigel R, Siegel RJ (2013) Management of mitral stenosis using 2D and 3D echo-Doppler imaging. J Am Coll Cardiol Imaging 6(11):1191–1205

    Article  Google Scholar 

  9. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M (2009) Echocardiographic assessment of valve stenosis: eAE/ASE recommendations for clinical practice. Eur J Echocardiogr 10(1):1–25

    Article  PubMed  Google Scholar 

  10. Chiampan A, Nahum J, Leye M, Oziel J, Cueff C, Brochet E, Iung B, Rossi A, Vahanian A, Messika-Zeitoun D (2012) Determinants of regurgitant volume in mitral regurgitation: contrasting effect of similar effective regurgitant orifice area in functional and organic mitral regurgitation. Eur Heart J Cardiovasc Imaging 13(4):324–329

    Article  PubMed  Google Scholar 

  11. Stoddard MF, Dawkins PR, Prince CR, Ammash NM (1995) Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 25(2):452–459

    Article  CAS  PubMed  Google Scholar 

  12. Bakshi R (2000) Diffusion-weighted MRI as an evolving standard of care in acute stroke. Neurology 55(10):1595

    Article  CAS  PubMed  Google Scholar 

  13. Selcuk MT, Selcuk H, Maden O, Temizhan A, Aksu T, Dogan M, Sasmaz A (2007) Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis. J Heart Valve Dis 16(5):468–474

    PubMed  Google Scholar 

  14. Perez-Gomez F, Salvador A, Zumalde J, Iriarte JA, Berjon J, Alegria E, Almeria C, Bover R, Herrera D, Fernandez C (2006) Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial. Eur Heart J 27(8):960–967

    Article  CAS  PubMed  Google Scholar 

  15. Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E (1970) Systemic embolism in mitral valve disease. Br Heart J 32(1):26–34

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Golbasi Z, Cicek D, Canbay A, Ucar O, Bayol H, Aydogdu S (2002) Left atrial appendage function in patients with mitral stenosis in sinus rhythm. Eur J Echocardiogr 3(1):39–43

    Article  CAS  PubMed  Google Scholar 

  17. Li YH, Hwang JJ, Lin JL, Tseng YZ, Lien WP (1996) Importance of left atrial appendage function as a risk factor for systemic thromboembolism in patients with rheumatic mitral valve disease. Am J Cardiol 78(7):844–847

    CAS  PubMed  Google Scholar 

  18. Atalar E, Ozmen F, Haznedaroglu I, Ozer N, Aksoyek S, Ovunc K, Nazli N, Kirazli S, Kes S (2002) Impaired fibrinolytic capacity in rheumatic mitral stenosis with or without atrial fibrillation and nonrheumatic atrial fibrillation. Int J Hematol 76(2):192–195

    Article  PubMed  Google Scholar 

  19. Yavuz B, Ertugrul DT, Yalcin AA, Kucukazman M, Ata N, Dal K (2009) Increased mean platelet volume in rheumatic mitral stenosis: a possible factor for thromboembolic events. J Cardiol 53(2):204–207

    Article  PubMed  Google Scholar 

  20. Kaymaz C, Ozdemir N, Erentug V, Sismanoglu M, Yakut C, Ozkan M (2003) Location, size, and morphologic characteristics of left atrial thrombi as assessed by transesophageal echocardiography in relation to systemic embolism in patients with rheumatic mitral valve disease. Am J Cardiol 91(6):765–769

    Article  PubMed  Google Scholar 

  21. Falgá C, Capdevila JA, Soler S, Rabuñal R, Sánchez Muñoz-Torrero JF, Gallego P, Monreal M, Investigators R (2007) Clinical outcome of patients with venous thromboembolism and renal insufficiency. Findings from the RIETE registry. Thromb Haemost 98(4):771–776

    PubMed  Google Scholar 

  22. Apostolakis S, Guo Y, Lane DA, Buller H, Lip GY (2013) Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial. Eur Heart J 34(46):3572–3579

    Article  CAS  PubMed  Google Scholar 

  23. Wanishsawad C, Weathers LB, Puavilai W (1995) Mitral regurgitation and left atrial thrombus in rheumatic mitral valve disease. A clinicopathologic study. Chest 108(3):677–681

    Article  CAS  PubMed  Google Scholar 

  24. Nunes MC, Handschumacher MD, Levine RA, Barbosa MM, Carvalho VT, Esteves WA, Zeng X, Guerrero JL, Zheng H, Tan TC, Hung J (2014) Role of LA shape in predicting embolic cerebrovascular events in mitral stenosis: mechanistic insights from 3D echocardiography. J Am Coll Cardiol Imaging 7(5):453–461

    Article  Google Scholar 

  25. Keenan NG, Cueff C, Cimadevilla C, Brochet E, Lepage L, Detaint D, Himbert D, Iung B, Vahanian A, Messika-Zeitoun D (2010) Usefulness of left atrial volume versus diameter to assess thromboembolic risk in mitral stenosis. Am J Cardiol 106(8):1152–1156

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

    Hyun-Jin Kim, Goo-Yeong Cho, Yong-Jin Kim, Hyung-Kwan Kim, Seung-Pyo Lee, Hack-Lyoung Kim, Jin Joo Park, Yeonyee E. Yoon, Joo-Hee Zo & Dae-Won Sohn

  2. Cardiovascular Center, Seoul National University Bundang Hospital, 82 Gumi-ro-173-gil, Bundang, Seongnam, Gyeonggi, 463-707, South Korea

    Goo-Yeong Cho, Jin Joo Park & Yeonyee E. Yoon

  3. Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea

    Hyun-Jin Kim, Yong-Jin Kim, Hyung-Kwan Kim, Seung-Pyo Lee & Dae-Won Sohn

  4. Cardiovascular Center, Seoul National University Boramae Medical Center, Seoul, South Korea

    Hack-Lyoung Kim & Joo-Hee Zo

Authors
  1. Hyun-Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Goo-Yeong Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yong-Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyung-Kwan Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Seung-Pyo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hack-Lyoung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jin Joo Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yeonyee E. Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Joo-Hee Zo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dae-Won Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Goo-Yeong Cho.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 42 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, HJ., Cho, GY., Kim, YJ. et al. Development of atrial fibrillation in patients with rheumatic mitral valve disease in sinus rhythm. Int J Cardiovasc Imaging 31, 735–742 (2015). https://doi.org/10.1007/s10554-015-0613-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-015-0613-2

Keywords

Search

Navigation